InsiderTrades

Form 4 for ABBV AbbVie

Accepted 2021-08-25 00:00:00 ET · period of report 2021-08-23 · accession 0001179110-21-008421 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-08-25 2021-08-23 ABBV Sorg Elaine K. SVP, US Commercial Ops S - Sale+OE $120.00 -13.1K 11.6K -53% -$1.57M
D 2021-08-25 2021-08-23 ABBV Sorg Elaine K. SVP, US Commercial Ops M - OptEx $114.36 +7,080 18.7K +61% +$809.7K
D 2021-08-25 2021-08-23 ABBV Sorg Elaine K. SVP, US Commercial Ops M - OptEx $0.00 -7,080 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.01 par value 2021-08-23 S D 7,080 $120.00 11,595 D — —
2 Common Common Stock, $0.01 par value 2021-08-23 M A 7,080 $114.36 18,675 D — —
3 Common Common Stock, $0.01 par value 2021-08-23 S D 6,000 $120.00 11,595 D — —
4 Derivative Option (Right to buy) 2021-08-23 M D 7,080 $0.00 0 D $114.36 · 2019-02-15 to 2028-02-14 7,080 Common Stock (F1) Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.